Form 4: Cingulate Inc. Director John A. Roberts Acquires Stock Options

Director John A. Roberts acquired stock options in Cingulate Inc. following stockholder approval of an amendment to the equity incentive plan.

Summary

• On June 11 and 12, 2024, John A. Roberts, a director of Cingulate Inc., acquired stock options to purchase shares of common stock.
• The options were granted at exercise prices of $1.18 and $0.70.
• 5,000 options vest 50% on the six-month anniversary of the grant date and the remaining 50% on the twelve-month anniversary.
• 14,750 options vest on the one-year anniversary of the grant date and were issued in lieu of $29,500 in cash retainer fees.
• 10,000 options vest on the one-year anniversary of the grant date.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a routine event, but it can signal confidence from the director in the company's future.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
• The issuance of options in lieu of cash retainer fees can conserve the company's cash resources.

Industry Context

Stock options are a common form of executive compensation in the pharmaceutical industry, aligning management's interests with those of shareholders.

Stakeholder Impact

• Shareholders may view the granting of stock options to a director as a positive sign of alignment between management and shareholder interests.
• Employees may be motivated by the knowledge that directors are incentivized to improve the company's performance.

Key Dates

Keywords

stock options, Cingulate Inc., director, John A. Roberts, equity incentive plan, beneficial ownership